<unk> cal and demographic information on<unk>  is not fully documented. Research in Belgium in 2004 approximated the incidence of<unk>  to be 249 per 100,000 individuals in Europe.<unk>  primarily affects individuals older than 50 years, with median ages between 55 and 60 years old. Data are inconclusive with regards to the predominant gender in<unk>  patients; studies have shown both a predominance in males and females in different patient population samples.
Erysipelas epidemiology and demographics
Dermatophytosis epidemiology and demographics
Impetigo epidemiology and demographics
Vertigo epidemiology and demographics
Byssinosis epidemiology and demographics
Onychomycosis epidemiology and demographics
Chickenpox epidemiology and demographics
Lyme disease epidemiology and demographics